OPKO HEALTH INC. - COMMON STOCK

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

09 يناير 2025 10:45:00 بحسب Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

07 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

12 ديسمبر 2024 10:21:35 بحسب NetDania Notify

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

20 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

07 نوفمبر 2024 15:05:11 بحسب Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

29 أكتوبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

07 أكتوبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

23 سبتمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: OPKO HEALTH INC. - COMMON STOCK

17 سبتمبر 2024 10:54:13 بحسب NetDania Notify

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

07 أغسطس 2024 15:06:35 بحسب Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

01 أغسطس 2024 15:05:00 بحسب Nasdaq GlobeNewswire

OPKO Health Announces $100 Million Share Repurchase Program

18 يوليو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

17 يوليو 2024 15:14:57 بحسب Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Global Healthcare Conference

31 مايو 2024 09:49:15 بحسب Nasdaq GlobeNewswire

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

07 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

03 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

05 مارس 2024 07:52:22 بحسب Nasdaq GlobeNewswire

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

27 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

22 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

09 يناير 2024 15:05:28 بحسب Nasdaq GlobeNewswire